Back to search

University of Minnesota

Nanodroplet-infused Mucoadhesive Wafers for Delivery of Poorly Soluble Compounds

Abstract

dc:description.abstract

Mucosal drug delivery is a drug delivery method with non-invasive administration, convenient dosing, and potential for localized delivery. Based on alginate (ALG) and carboxymethyl cellulose (CMC), hydrophilic mucoadhesive wafers have been used in mucosal drug delivery systems, but their application in delivering poorly water soluble drugs is still limited by drug dispersion, release controllability, and effective distribution within tissues. To expand the applicability of this type of wafer platform for poorly water soluble drugs, an amphiphilic liquid polymer PA11 was introduced in this study, and Nile Red was used as a hydrophobic model drug to construct a PA11 loaded mucoadhesive wafer system, and the effects of PA11 content and Ca²⁺ crosslinking on material formability, mechanical properties, microstructure, and drug delivery behavior were systematically studied. The results showed that PA11 was incorporated into the ALG/CMC wafer system and formed a relatively uniform fluorescence distribution within the material. At low to moderate PA11 concentrations (0-20 mg/mL), the overall morphology and mechanical behavior of the wafer remained relatively stable, while higher PA11 content (> 50 mg/mL) affected the structural integrity and formability of the regular wafer. Ca²⁺ crosslinking enhanced the mechanical properties of the wafer and improved structural stability under high PA11 content conditions, but weaken the adhesive ability of wafer. Microscopic structure observation showed that crosslinking altered the pore structure of the wafer, resulting in a more open and interconnected network. For drug delivery behavior, the regular (uncross-linked) wafer showed obvious swelling and structural disintegration on the surface of gelatin hydrogel (as a mimic of soft biological tissue) and was accompanied by extensive lateral diffusion, while the crosslinked wafer maintained better structural stability during the experiment, and drug distribution was more concentrated beneath the wafer and showed more pronounced depth wise penetration characteristics. For both wafer type, drug concentration gradually decreased with increasing gelatin gel depth, forming a concentration gradient decreasing from the wafer/gelatin interface toward the interior. In addition, the regular wafer had a higher fraction of drug release into the gelatin gel in a short time but was accompanied by higher drug loss, while the crosslinked wafer had a lower initial release fraction but reduced drug leakage and retained more drug within the system. In conclusion, a PA11-nanodroplet-infused composite mucoadhesive wafer system was constructed and characterized. These studies have established the feasibility of these wafers for delivering poorly water-soluble drugs across the wafer/soft-tissue interface.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tian, Xiaoyu

Subjects

dc:subject × 6

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Tian, Xiaoyu. (2026). Nanodroplet-infused Mucoadhesive Wafers for Delivery of Poorly Soluble Compounds. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/282271.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Tian, Xiaoyu. Nanodroplet-infused Mucoadhesive Wafers for Delivery of Poorly Soluble Compounds. 2026. https://hdl.handle.net/11299/282271